Introduction
Techniques producing highly conformal dose distribution such as intensity-modulated radiation therapy (IMRT) can facilitate normal tissue sparing and escalating the dose to the target. However, in thoracic radiotherapy, geometric uncertainty increases, and dose conformality decreases in spite of applying this technique because the organs and tumor are moved and deformed by respiratory motion. Accordingly, underdosing to target and overdosing to normal tissue could occur. Four-dimensional (4D) computed tomography (CT) offers information regarding respiration-induced tumor and organ motion in the form of three-dimensional (3D) CT data sets according to the respiratory cycle. 1, 2) Generally in clinics, internal target volume (ITV)-based treatment planning, which uses an additional margin to consider the geometric uncertainties caused by respiratory motion, 3) is performed using 4D
CT data. Although the ITV-based treatment planning is performed, a planned dose distribution, which was 2 www.ksmp.or.kr calculated from the treatment planning systems, may differ from the corresponding delivered dose distribution, which was the actual radiation dose to patient.
One of the reasons for the discrepancy between the planned and delivered dose is that the planned dose,
i.e., a 3D dose, may not reflect the dosimetric impact of respiration-induced organ motion and deformation despite ITV-based treatment planning. 4) Currently, a 4D dose calculation, which could reflect the dosimetric impact of respiratory motion and estimate a more realistic delivered dose than a 3D dose, can be performed using the 4DCT data and a deformable image registration (DIR), and various studies related to the 4D dose calculation have been conducted. [5] [6] [7] [8] [9] [10] [11] [12] [13] Guckenberger et al. 10) compared the 3D and 4D dose in terms of a biological effective dose (BED) in seven patients.
There was no significant difference between the 3D and 4D
dose for gross tumor volume (GTV) and ITV at the isocenter.
However, the 3D dose significantly underestimated the 4D dose at a planning target volume (PTV) margin. Starkchall et al. 7) investigated 15 patients with Stage III non-small-cell lung cancer. In six patients, the difference between the 3D and 4D dose in the clinical target volume (CTV) coverage was more than 3%, and in five patients, a significant difference of at least 5% in the PTV coverage was identified, which warranted replanning.
Several prior studies of liver and lung tumors identified that tumor size and motion could be linked to the difference. 8, 12) In particular, in lung cancer patients, Valdes et al. 8) expected that small tumor with large motion will show significant difference. Estimating the condition of factors such as tumor size and motion underlying this significant difference is important because the 4D dose does not always provide significant advantage than the 3D dose to all patients, despite reflecting the dosimetric impact of the respiratory motion. 13) To 
Materials and Methods

Phantom design and construction
A phantom design was based on the deformable lung 14) The phantom consisted of target, motion, and respiratory signal components to simulate the lung, diaphragm motion, and thorax motion (Fig. 1a) .
The target component was manufactured to simulate the lung and consisted of two acrylic cylinders of different sizes, a sponge, and a silicone tumor. The acrylic cylinders were 18 cm in height, with diameters of 12 cm and 18 cm.
The cylinder of 12 cm diameter was inserted and fixed inside the cylinder of 18 cm diameter. A wet sponge was used to emulate the deformation and electron density of the lung. This method was referred from prior studies. 15, 21) The wet sponge including the tumor was inserted into the cylinder set as shown in ( )
where r is the radius of rotation, θ i is the initial angle before moving the phantom and θ f is the final angle after moving the phantom.
In addition, the programmable motor can control the period with regular breathing via programmable motor functions. Therefore, the amplitude of the phantom diaphragm motion was controlled by adjusting the radius of rotation using the adjustable rotation axis crank and length adjustment driving rod. In addition, to simulate tumor motion by ≥3 cm, the phantom diaphragm motion could be controlled in the range 1~7 cm.
The respiratory signal component was manufactured to simulate the thorax motion and acquire a respiratory signal 
Verification of the phantom diaphragm motion
The accuracy of the phantom diaphragm motion was evaluated by comparing the phantom equation of motion (set by Eq. (1) 
4DCT data acquisition
To evaluate the phantom performance in terms of controlling the tumor size and motion, the 4DCT data were acquired using a CT scanner (SOMATOM Definition AS, Siemens Healthcare, Erlangen, Germany) with the ANZAI belt ( 
Assessment of tumor motion and position
On the basis of the center-of-mass (COM) of the tumor and the spherical metal marker (Fig. 1c) 
Results
4DCT image of the phantom
Verification of phantom diaphragm motion
The difference between the equation and measured motion was less than 1 mm, ranging from 0.1~0.9 mm, in all cases (Table 1) . A maximum difference of 0.9 mm occurred for a radius of rotation of 10 mm, and the mean absolute error (MAE) between the equation and measured motion was 0.34 mm.
Tumor motion and position
The trajectories of the tumor COM were mainly in the superior-inferior (SI) direction for the 10 cm 3 and 90 cm 3 tumor cases (Table 2 ). In the case of a 10 cm The correlation curve shows that as the diaphragm motion increased, the tumor motion in the SI direction increased. 
Discussion
The developed deformable lung phantom simulated indirect tumor motion and deformation via compression and decompression of a sponge using the phantom diaphragm motion instead of directly moving a tumor using a motor.
Thus, the direction of the tumor motion was affected by the phantom diaphragm motion. Several studies showed that lower lobe tumor motions occurred mostly in the SI direction and had larger amplitude movement than upper lobe tumors. 18, 19) In addition, large tumor motion may be more closely associated with the difference between the 3D and 4D dose calculations than small motion. Therefore, the phantom simulated a tumor located in the lower lobe.
The MAE of 0.34 mm for the verification of the phantom diaphragm motion from Table 1 The correlation curve between the phantom diaphragm and tumor motion in the SI direction (Fig. 7) had a similar and size. However, the electron density of the lung and tumor hardness were simulated by referring to previous studies. 15, 16) Dosimeters such as film and thermoluminescent dosimeters were not considered because this phantom is intended for a comparative analysis between the 3D and 4D dose calculations. However, it is technically possible to embed these dosimeters in the silicone tumors or sponge.
In this study, an example of a 4D dose distribution based on 3D conformal radiation therapy planning was distributions are calculated at each phase on the basis of the same treatment planning that is planned on the reference phase (end-exhalation) image of four-dimensional computed tomography. Deformation vector fields (DVFs) between the reference and the other phase images are acquired using the deformable image registration. These DVFs applied the 3D dose distribution, which is dose warping, and the dose distributions deformed by the DVFs were summed with equal weighting. Fig. 9 , and this process is similar to that from previous studies. 6, 12) Fig. 10 shows the 3D dose distribution, 4D dose distribution, and the distribution of difference between the 3D and 4D dose, and this difference mainly occurred in the SI direction. The tendency of this difference was similar to that reported by a previous study using patient cases. 12) In further study, the effects of the factors that influence the difference between the 3D and 4D dose calculations, such as tumor size and motion, will be quantitatively analyzed using this phantom. Ultimately, the phantom could contribute to the discrimination of patients who would benefit from the 4D dose by estimating the condition of significant difference between the 3D dose and 4D dose according to the tumor size and motion.
Conclusion
The developed deformable lung phantom was designed to control the tumor size and motion. The tumor motion can be controlled using the acquired correlation curve between the phantom diaphragm and tumor motion.
Furthermore, the tumor size can be controlled by producing tumors of various sizes using liquid silicone rubber and custom tumor molds created using a 3D printer. 
